Author: McGregor Maurice
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.24, Iss.10, 2006-01, pp. : 947-952
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost-Effectiveness League Tables: Valuable Guidance for Decision Makers?
By Mauskopf J.
PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. :
Do Pharmacogenomic Tests Provide Value to Policy Makers?
PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. :
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 349, 2002-01 ,pp. :
Should We Abandon QALYs as a Resource Allocation Tool?
PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. :
QALYs: at best, empty and meaningless; at worst, harmful?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. :